Terms: = Ovarian cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
40 results:
1. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
[TBL] [Abstract] [Full Text] [Related]
2. Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey.
Kim JH; Lee Y; Kim DY; Kim S; Seo SS; Kang S; Park SY; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e3. PubMed ID: 37681357
[TBL] [Abstract] [Full Text] [Related]
3. Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced ovarian cancer: A Clinical Study of 100 Patients.
Zhang J; Li XB; Ji ZH; Ma R; Bai WP; Li Y
Biomed Res Int; 2021; 2021():5533134. PubMed ID: 34258265
[TBL] [Abstract] [Full Text] [Related]
4. Ezrin Promotes the Proliferation, Migration, and Invasion of ovarian cancer Cells.
Li MJ; Xiong D; Huang H; Wen ZY
Biomed Environ Sci; 2021 Feb; 34(2):139-151. PubMed ID: 33685573
[TBL] [Abstract] [Full Text] [Related]
5. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of rhoa.
El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
[TBL] [Abstract] [Full Text] [Related]
6. Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness.
Karvonen H; Arjama M; Kaleva L; Niininen W; Barker H; Koivisto-Korander R; Tapper J; Pakarinen P; Lassus H; Loukovaara M; Bützow R; Kallioniemi O; Murumägi A; Ungureanu D
Cell Death Dis; 2020 Sep; 11(9):790. PubMed ID: 32989221
[TBL] [Abstract] [Full Text] [Related]
7. Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report.
Simmons AD; Nguyen M; Pintus E
BMC Cancer; 2020 Mar; 20(1):215. PubMed ID: 32171277
[TBL] [Abstract] [Full Text] [Related]
8. SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma.
Liu CL; Pan HW; Torng PL; Fan MH; Mao TL
Oncol Rep; 2019 Dec; 42(6):2706-2715. PubMed ID: 31638245
[TBL] [Abstract] [Full Text] [Related]
9. Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways.
Zhang X; Hou G; Liu A; Xu H; Guan Y; Wu Y; Deng J; Cao X
Cell Death Dis; 2019 Oct; 10(10):770. PubMed ID: 31601793
[TBL] [Abstract] [Full Text] [Related]
10. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
[TBL] [Abstract] [Full Text] [Related]
11. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract] [Full Text] [Related]
12. MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research.
Chen X; Li X; Wang X; Zhu Q; Wu X; Wang X
BMC Cancer; 2019 Feb; 19(1):171. PubMed ID: 30795761
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
Chen Y; Ning Y; Zhang Q; Xie Y
Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
[TBL] [Abstract] [Full Text] [Related]
14. SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the rhoa/ROCK signaling pathway.
Wang W; Du H; Liu H; Hu F; Liu G
Oncol Rep; 2019 Jan; 41(1):668-676. PubMed ID: 30542716
[TBL] [Abstract] [Full Text] [Related]
15. Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility.
Kapoor A; Barai A; Thakur B; Das A; Patwardhan SR; Monteiro M; Gaikwad S; Bukhari AB; Mogha P; Majumder A; De A; Ray P; Sen S
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):392-405. PubMed ID: 29175377
[TBL] [Abstract] [Full Text] [Related]
16. O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the rhoa/ROCK/MLC pathway.
Niu Y; Xia Y; Wang J; Shi X
Mol Med Rep; 2017 Apr; 15(4):2083-2089. PubMed ID: 28259907
[TBL] [Abstract] [Full Text] [Related]
17. rhoa/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
[TBL] [Abstract] [Full Text] [Related]
18. Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through Wnt/PCP signaling and FAK/SRC pathway.
Sun L; Wang D; Li X; Zhang L; Zhang H; Zhang Y
Biomed Pharmacother; 2016 Jul; 81():145-151. PubMed ID: 27261588
[TBL] [Abstract] [Full Text] [Related]
19. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.
Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC
Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988
[TBL] [Abstract] [Full Text] [Related]
20. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
[TBL] [Abstract] [Full Text] [Related]
[Next]
